Bi­par­ti­san group of law­mak­ers op­pos­es Biden's plan to use 'march-in' to low­er drug prices

A group of 28 sen­a­tors and mem­bers of Con­gress, in­clud­ing nine De­moc­rats, sent a let­ter to Pres­i­dent Joe Biden on Wednes­day de­cry­ing his ad­min­is­tra­tion’s re­cent pro­pos­al to ex­er­cise its so-called march-in rights when drug prices rise too high.

Biden’s plan, un­veiled in De­cem­ber in guid­ance from the Na­tion­al In­sti­tute of Stan­dards and Tech­nol­o­gy, would al­low the gov­ern­ment to con­sid­er the price of a drug when de­cid­ing whether to take over patents on in­ven­tions de­vel­oped with the help of fed­er­al­ly-fund­ed re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER